Baltimore, Maryland (PRWEB) June 16, 2016 -- Gemstone Biotherapeutics LLC (Gemstone Bio), a Baltimore-based biotechnology company and pioneer in the field of regenerative medicine technologies for advanced wound care, announced the appointment of Dr. Marc Dauer, M.D. as a new advisor for Gemstone Bio.
Dr. Dauer is a world-renowned leader in modern hair restoration techniques, bringing over 15 years of experience understanding hair transplantation and hair loss. He is the medical director of Dauer Hair Restoration, where he focuses on follicular hair transplantation to achieve natural hair transplant results.
“Marc brings a deep understanding of hair restoration techniques. As a clinical advisor with significant expertise, he will provide Gemstone Bio with input that will assist and guide us as we assess the potential of our biosynthetic scaffold for hair restoration,” said George Davis, CEO of Gemstone Bio. “As we move our platform technology forward, we continue to explore diverse potential applications.”
“I am thrilled to be added as an advisor to Gemstone Bio and have the opportunity to incorporate their innovative technology into hair restoration techniques. I look forward to working closely with the team to explore new ways we can help patients who are struggling with hair loss,” said Dauer.
Dr. Dauer graduated with honors from New York Medical College and trained in the Department of Head and Neck Surgery at UCLA Medical Center. He subsequently received special training in Hair Restoration and has been a published author in numerous medical publications in the practice area of hair transplantation. Dr. Dauer, located in Los Angeles, is also a Diplomate of the American Board of Hair Restoration Surgery, Diplomate of the National Board of Medical Examiners, and an active member of the International Society of Hair Restoration Surgery. Dr. Dauer is a teaching faculty member of the American Academy of Aesthetic Medicine, and routinely conducts teaching conferences around the world instructing hair transplant physicians in the art of Follicular Unit Hair Transplantation.
ABOUT GEMSTONE BIOTHERAPEUTICS
Gemstone Biotherapeutics LLC (Gemstone Bio), an award-winning regenerative medicine company based in Baltimore, is developing devices and therapeutics for advanced wound care. The company’s core technologies target cellular deficiencies to promote tissue repair and regeneration. Gemstone Bio is advancing these technologies, originally created in laboratories at the School of Engineering and Medicine at Johns Hopkins University. For more information, visit http://www.gemstonebio.com.
Adrienne Peres, Abel Communications, http://www.abelcommunications.com, +1 443.869.2197 Ext: 146, [email protected]
Share this article